Winfield Associates’s Zimmer Biomet ZBH Stock Holding History

Winfield Associates’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-32	Closed	-$3K	–	313
2015 Q2	$3K	Hold	32	–	–	﹤0.01%	272
2015 Q1	$4K	Buy	32 +6	+23%	+$685	﹤0.01%	274
2014 Q4	$3K	Buy	+26	New	+$2.74K	﹤0.01%	286
2014 Q2	–	Sell	-31	Closed	-$3K	–	311
2014 Q1	$3K	Hold	31	–	–	﹤0.01%	280
2013 Q4	$3K	Buy	+31	New	+$2.68K	﹤0.01%	271

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Winfield Associates's ZBH Position: Q3 2015 in Review

Winfield Associates sold out of Zimmer Biomet (ZBH) in Q3 2015, closing a stake of 32 shares — an estimated $3K sold.

Winfield Associates first reported a position in ZBH in Q4 2013 and held it in 5 quarters. The position peaked at $4K in Q1 2015. 725 funds tracked by Wall St. Rank hold ZBH as of Q3 2015.

Winfield Associates reported no remaining Zimmer Biomet position as of Q3 2015 after selling out during the quarter.
Winfield Associates sold 32 Zimmer Biomet shares in Q3 2015, an estimated $3K.
Winfield Associates first reported a position in Zimmer Biomet in Q4 2013 and held it in 5 quarters.
Winfield Associates's Zimmer Biomet position peaked at $4K in Q1 2015.
725 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2015.

Based on Winfield Associates's 13F filing for Q3 2015, filed 6 Nov 2015.